Rates of response to OCA therapy stratified according to the presence of liver cirrhosis (left panel), PBC-AIH overlap (mid panel) and centre level (right panel).
Response estimated based on POISE (upper panels) and normal range criteria (lower panels) in the overall cohort and treatment completer cohort. ∗p <0.05 and ∗∗p <0.01 using the χ2 test. AIH, autoimmune hepatitis; OCA, obeticholic acid; PBC, primary biliary cholangitis.